ArticleMolecular oncology2019

The Ibr-7 derivative of ibrutinib exhibits enhanced cytotoxicity against non-small cell lung cancer cells via targeting of mTORC1/S6 signaling.

Bo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.